<?xml version="1.0"?>
<rss version="2.0">
    <channel>
        <title>ASLME Ted Lines RSS Feed</title>
        <description>Review the latest posts by ASLME Publications Director Ted Hutchinson - 
        then respond with your own thoughts and insights. We also invite you to participate 
        in our forums or drop a note in our suggestion box. This is your page - and your 
        opportunity to shape the debate. So jump right in, and check back often to see what's new. </description>
        <link>http://www.aslme.org/Ted_Lines</link>
	<item>
            <title>Headlines: November 28, 2011</title>
            <pubDate>2011-11-28 13:00</pubDate>
            <description>A review of 8 states shows that the trend of parents opting out of getting vaccination for their children is still on the rise. An Associated Press analysis found that more than 1 in 20 kindergartners arent getting the vaccines traditionally required for school attendance. The analysis also shows that more than half of the states in the U.S. have seen an increase in the rate of exemptions over ...</description>
            <link>http://www.aslme.org/Ted_Lines?post=421</link>
        </item>
	<item>
            <title>Headlines: November 21, 2011</title>
            <pubDate>2011-11-21 13:00</pubDate>
            <description>On Friday, the FDA announced it was revoking approval for the cancer drug Avastin for treatment of breast cancer. The FDA Commissioner, Dr. Margaret A. Hamburg, said that clinical trials show the drug was not helping breast cancer patients live longer, nor was it meaningfully controlling their tumors. Combined with the lack of efficacy were concerns with exposing breast cancer patients to seriou...</description>
            <link>http://www.aslme.org/Ted_Lines?post=420</link>
        </item>
	<item>
            <title>Headlines: November 18, 2011</title>
            <pubDate>2011-11-18 13:00</pubDate>
            <description>Geron, the first company to engage in government-approved testing of embryonic stem cell therapy, is discontinuing further stem cell work. The company attributed its exit due to financial constraints and not because of scientific setbacks in the often-controversial field. Citing capital setbacks, Geron decided to use its resources to fund further cancer trials, and hopes to find a corporate pa...</description>
            <link>http://www.aslme.org/Ted_Lines?post=419</link>
        </item>
	<item>
            <title>Headlines: November 14, 2011</title>
            <pubDate>2011-11-14 13:00</pubDate>
            <description>The Supreme Court announced this morning that it will rule on the constitutionality of health care reform this term. A spokeswoman for the Supreme Court said oral arguments will take place in March, with five and a half hours of time devoted. The ruling will come down by the end of the term in late June, leading into a contentious election that may be centered on the controversial law. At the h...</description>
            <link>http://www.aslme.org/Ted_Lines?post=418</link>
        </item>
	<item>
            <title>Headlines: November 7, 2011</title>
            <pubDate>2011-11-07 13:00</pubDate>
            <description>A new analysis by the American Institute for Cancer Research shows that prolonged periods of sitting and physical inactivity account for upwards of 90,000 cases of cancer each year. Breast cancer and colon cancer, in particular, have a high correlation with physical inactivity. Even those who exercise regularly and otherwise maintain a healthy lifestyle may have an increased risk of cancer just ...</description>
            <link>http://www.aslme.org/Ted_Lines?post=416</link>
        </item>
</channel></rss>
